1. Academic Validation
  2. Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer

Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer

  • J Med Chem. 2024 Feb 22;67(4):2238-2263. doi: 10.1021/acs.jmedchem.3c01749.
Tong-Mei Shi 1 Xiao-Fei Chen 2 Huihui Ti 1 3
Affiliations

Affiliations

  • 1 School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China.
  • 2 Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Institute of Analysis, Guangdong Academy of Sciences, China National Analytical Center, Guangzhou, Guangzhou 510070, P. R. China.
  • 3 Guangdong Province Precise Medicine Big Data of Traditional Chinese Medicine Engineering Technology Research Center, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China.
Abstract

Ferroptosis is a type of iron-dependent programmed cell death characterized by the dysregulation of iron metabolism and the accumulation of lipid peroxides. This nonapoptotic mode of cell death is implicated in various physiological and pathological processes. Recent findings have underscored its potential as an innovative strategy for Cancer treatment, particularly against recalcitrant malignancies that are resistant to conventional therapies. This article focuses on ferroptosis-based therapeutic strategies for precision Cancer treatment, covering the molecular mechanisms of Ferroptosis, four major types of Ferroptosis inducers and their inhibitory effects on diverse carcinomas, the detection of Ferroptosis by fluorescent probes, and their implementation in image-guided therapy. These state-of-the-art tactics have manifested enhanced selectivity and efficacy against malignant carcinomas. Given that the administration of Ferroptosis in Cancer therapy is still at a burgeoning stage, some major challenges and future perspectives are discussed for the clinical translation of Ferroptosis into precision Cancer treatment.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-162065
    98.37%, Ferroptosis Inducer